Skip to content

Author

N. Sutandyo

We have 3 of 104 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Determinants of survival in triple-negative breast cancer: A clinicopathological study from an Indonesian Cancer Center

A BSTRACT Triple-negative breast cancer (TNBC) outcomes in Southeast Asian and resource-limited settings remain underreported. This study evaluated factors associated with 3-year overall survival (OS), event-free survival (EFS) in stage I–IIIC disease, and progression-free survival (PFS) in stage IV disease....

S. Haryono, Yuniar Harris Prayitno, N. Sutandyo · 0 citations
Review Open access Aug 2026

Targeting tumor associated macrophages to alternate cancer stem cells and tumor microenvironment milieu

Macrophages in the tumor microenvironment are involved in promoting cancer growth and enabling it to evade therapies. By acting as something like a tumor's "underground," these cells dampen down the "calls for help" that chemotherapy or radiotherapy might otherwise trigger. They also appear to enable some cells in the...

Mahdaleny Mahdaleny, Septelia Inawati Wanandi, N. Sutandyo et al. · 0 citations
Open access Jul 2026

Integrated Bioinformatics and RT-qPCR Validation Identify Candidate Biomarkers Associated with EGFR-TKI Resistance in EGFR-Mutant Lung Adenocarcinoma

Integrated bioinformatics analysis identified TGFA, DDIT4, and SOX9 as candidate genes associated with EGFR-TKI resistance in EGFR-mutant lung adenocarcinoma, providing a basis for further investigation of resistance-associated biomarkers.

M. A. Hanif, Fadilah, N. Sutandyo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.